Zobrazeno 1 - 10
of 164
pro vyhledávání: '"Hideki, Akiyama"'
Autor:
Kai Inoue, Hanako Aoki, Shuta Toru, Yu Hatano, Reina Imase, Hiroshi Takasaki, Michiko Tanaka, Saori Adachi, Hiroaki Yokote, Hideki Akiyama, Michio Yamane
Publikováno v:
Radiology Case Reports, Vol 19, Iss 3, Pp 855-858 (2024)
Coronavirus disease 2019 (COVID-19) causes a systemic inflammatory response and a temporary immunosuppression of hosts. Several reports have showed that reactivation of herpes simplex virus type 1 (HSV-1) is strongly associated with COVID-19. We pres
Externí odkaz:
https://doaj.org/article/7bf065b8740e4545b8af03b1697be7f6
Autor:
Takeshi Hagino, Nelson Hirokazu Tsuno, Fumihiro Azuma, Hideo Ohtani, Reina Matsui, Chie Someya, Yutaka Kato, Satoko Osanai, Hiroko Hidai, Hisashi Tsutsumi, Hideki Akiyama, Sayuri Motomura, Tetsunori Tasaki
Publikováno v:
Platelets, Vol 30, Iss 6, Pp 799-801 (2019)
The efficacy of 30 platelet concentrate (PC) products transfused to a patient with myelodysplastic syndrome (MDS) was evaluated by calculating the 1-hour post-transfusion corrected count increment (1h-CCI). Of the 30 transfusions, all HLA-A/B-matched
Externí odkaz:
https://doaj.org/article/9ece142854974266b4ef019d8b96c410
Autor:
Takeshi Hagino, Tomohiko Sato, Reina Saga, Hiroko Hidai, Yoshiro Murai, Hideki Akiyama, Sayuri Motomura
Publikováno v:
International journal of hematology. 116(6)
The development of myeloid leukocytosis in leukemia patients during antileukemic treatment requires a differential diagnosis between myeloid leukemoid reaction and leukemia progression. We herein report the case of an 80-year-old Japanese man with ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33af5f63b4c3c6edebf754a70438289f
https://pubmed.ncbi.nlm.nih.gov/35852697
https://pubmed.ncbi.nlm.nih.gov/35852697
Autor:
Miki Umeda, Hisashi Tsutsumi, Wataru Shinomiya, Hiroko Hidai, Hideki Akiyama, Yoshiaki Shibata, Reina Saga, Takeshi Hagino, Sayuri Motomura, Miwa Kurimoto
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 45:828-831
What is known and objective 5-Azacitidine (AZA) is an agent widely used to treat myelodysplastic syndrome (MDS). Case description We herein report an 83-year-old woman diagnosed with MDS who was treated with AZA. She tolerated the first cycle of AZA;
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42ce0ecb9231a9246e29181c94ecfc9e
https://doi.org/10.1111/jcpt.13146
https://doi.org/10.1111/jcpt.13146
Autor:
Sayuri Motomura, Tetsunori Tasaki, Fumihiro Azuma, Hisashi Tsutsumi, Yutaka Kato, Reina Matsui, Satoko Osanai, Takeshi Hagino, Hideo Ohtani, Hideki Akiyama, Chie Someya, Hiroko Hidai, Nelson Hirokazu Tsuno
Publikováno v:
Platelets. 30:799-801
The efficacy of 30 platelet concentrate (PC) products transfused to a patient with myelodysplastic syndrome (MDS) was evaluated by calculating the 1-hour post-transfusion corrected count increment (1h-CCI). Of the 30 transfusions, all HLA-A/B-matched
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fd825a3eb1799c53b40816d3708f475
https://doi.org/10.1080/09537104.2019.1609664
https://doi.org/10.1080/09537104.2019.1609664
Autor:
J Luis Espinoza, Akiyoshi Takami, Katsuya Nakata, Makoto Onizuka, Takakazu Kawase, Hideki Akiyama, Koichi Miyamura, Yasuo Morishima, Takahiro Fukuda, Yoshihisa Kodera, Shinji Nakao, Japan Marrow Donor Program
Publikováno v:
PLoS ONE, Vol 6, Iss 10, p e26229 (2011)
Interleukin IL-17 is a proinflammatory cytokine that has been implicated in the pathogenesis of various autoimmune diseases. The single nucleotide polymorphism (SNP), rs2275913, in the promoter region of the IL-17 gene is associated with susceptibili
Externí odkaz:
https://doaj.org/article/145826f403f048f8904f6e7d681b9802
Autor:
Luis J Espinoza, Akiyoshi Takami, Katsuya Nakata, Kayoko Yamada, Makoto Onizuka, Takakazu Kawase, Hiroshi Sao, Hideki Akiyama, Koichi Miyamura, Shinichiro Okamoto, Masami Inoue, Takahiro Fukuda, Yasuo Morishima, Yoshihisa Kodera, Shinji Nakao, Japan Marrow Donor Program
Publikováno v:
PLoS ONE, Vol 6, Iss 8, p e23827 (2011)
Serine protease granzyme B plays important roles in infections, autoimmunity, transplant rejection, and antitumor immunity. A triple-mutated granzyme B variant that encodes three amino substitutions (Q48R, P88A, and Y245H) has been reported to have a
Externí odkaz:
https://doaj.org/article/49226eb624d5478481b10abfd0135fdc
Autor:
J. Luis Espinoza, Akiyoshi Takami, Makoto Onizuka, Hiroshi Sao, Hideki Akiyama, Koichi Miyamura, Shinichiro Okamoto, Masami Inoue, Yoshinobu Kanda, Shigeki Ohtake, Takahiro Fukuda, Yasuo Morishima, Yoshihisa Kodera, Shinji Nakao
Publikováno v:
Haematologica, Vol 94, Iss 10 (2009)
Background NKG2D, an activating and co-stimulatory receptor expressed on natural killer cells and T cells, plays pivotal roles in immunity to microbial infections as well as in cancer immunosurveillance. This study examined the impact of donor and re
Externí odkaz:
https://doaj.org/article/e1758e56609c43f18240ee65d6ef5dc2
Autor:
Fumihiko Kimura, Ken Sato, Shinichi Kobayashi, Takashi Ikeda, Hiroshi Sao, Shinichiro Okamoto, Koichi Miyamura, Shinichiro Mori, Hideki Akiyama, Makoto Hirokawa, Hitoshi Ohto, Hiroshi Ashida, Kazuo Motoyoshi
Publikováno v:
Haematologica, Vol 93, Iss 11 (2008)
Background Although the AB0 blood group is one of two major antigen systems of relevance for transplantation in humans, there are still conflicting data concerning the influence of AB0 incompatibility on transplant outcome. This study investigated th
Externí odkaz:
https://doaj.org/article/cbcb4c7bdb934637badd38feac4144cc
Autor:
Masamitsu Yanada, Jin Takeuchi, Isamu Sugiura, Hideki Akiyama, Noriko Usui, Fumiharu Yagasaki, Kazuhiro Nishii, Yasunori Ueda, Makoto Takeuchi, Shuichi Miyawaki, Atsuo Maruta, Hiroto Narimatsu, Yasushi Miyazaki, Shigeki Ohtake, Itsuro Jinnai, Keitaro Matsuo, Tomoki Naoe, Ryuzo Ohno
Publikováno v:
Haematologica, Vol 93, Iss 2 (2008)
To identify factors associated with relapse-free survival (RFS), 80 patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia, enrolled in a phase II study of imatinib-combined chemotherapy, were analyzed. The median
Externí odkaz:
https://doaj.org/article/5e4b4da313874836a8be830d424b4481